Evidence map›Paper›PMID 31255298›Full record

ArticleLancet (London, England)2019

HPV vaccines can be the hallmark of cancer prevention.

Silvia de Sanjose, Sinead Delany-Moretlwe

Registry-linked trialAbstract readComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05838157 (Research for the Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05838157 unknown statusnot on this mapstarted 2023, after this paper: background citation

Research for the Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

TypeobservationalSponsorSun Yat-sen UniversityRan2023 to 2024Enrolled600ConditionsMenstrual Disorder, Premature Ovarian FailureArmsprophylactic HPV vaccine(bivalent HPV、quadrivalent HPV、9-valent HPV)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Cancer chemoprevention: signaling pathways and strategic approaches.Signal transduction and targeted therapy · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Catching viral breast cancer.Infectious agents and cancer · 2021
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Silvia de SanjosePATH, Seattle, WA 98121, USA. Electronic address: sdesanjose@path.org.
Sinead Delany-MoretlweWits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsFemaleHumansImmunizationVaccinationPapillomavirus Vaccines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.